MacroGenics, Inc.
MGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $148,339 | $57,193 | $150,018 | $75,643 |
| % Growth | 159.4% | -61.9% | 98.3% | – |
| Cost of Goods Sold | $12,299 | $8,222 | $7,384 | $2,651 |
| Gross Profit | $136,040 | $48,971 | $142,634 | $72,992 |
| % Margin | 91.7% | 85.6% | 95.1% | 96.5% |
| R&D Expenses | $177,194 | $166,583 | $207,026 | $214,577 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $71,047 | $52,188 | $58,949 | $63,014 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,623 | -$1,556 | -$1,923 | -$1,804 |
| Operating Expenses | $246,618 | $217,215 | $264,052 | $275,787 |
| Operating Income | -$110,578 | -$168,244 | -$121,418 | -$202,795 |
| % Margin | -74.5% | -294.2% | -80.9% | -268.1% |
| Other Income/Exp. Net | $44,556 | $159,186 | $1,660 | $680 |
| Pre-Tax Income | -$66,022 | -$9,058 | -$119,758 | -$202,115 |
| Tax Expense | $944 | $0 | $0 | $0 |
| Net Income | -$66,966 | -$9,058 | -$119,758 | -$202,115 |
| % Margin | -45.1% | -15.8% | -79.8% | -267.2% |
| EPS | -1.07 | -0.15 | -1.95 | -3.18 |
| % Growth | -613.3% | 92.3% | 38.7% | – |
| EPS Diluted | -1.07 | -0.15 | -1.95 | -3.18 |
| Weighted Avg Shares Out | 62,621 | 61,929 | 61,414 | 59,945 |
| Weighted Avg Shares Out Dil | 62,621 | 61,929 | 61,433 | 59,945 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,421 | $9,686 | $1,700 | $680 |
| Interest Expense | $1,115 | $1,430 | $0 | $0 |
| Depreciation & Amortization | $7,540 | $9,645 | $11,865 | $11,258 |
| EBITDA | -$57,367 | $2,017 | -$107,893 | -$190,857 |
| % Margin | -38.7% | 3.5% | -71.9% | -252.3% |